Corcept Therapeutics
CORT
#3418
Rank
S$5.44 B
Marketcap
S$51.68
Share price
2.11%
Change (1 day)
-43.25%
Change (1 year)

Market capitalization of Corcept Therapeutics (CORT)

Market cap: S$5.44 Billion

As of February 2026 Corcept Therapeutics has a market cap of S$5.44 Billion. This makes Corcept Therapeutics the world's 3418th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Corcept Therapeutics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026S$5.44 B-51.3%
2025S$11.18 B49.63%
2024S$7.47 B69%
2023S$4.42 B50.86%
2022S$2.93 B-5.16%
2021S$3.09 B-23.13%
2020S$4.02 B115.16%
2019S$1.86 B-11%
2018S$2.09 B-23.84%
2017S$2.75 B136.29%
2016S$1.16 B51.05%
2015S$0.77 B92.16%
2014S$0.40 B-1.02%
2013S$0.40 B132.65%
2012S$0.17 B-53.21%
2011S$0.37 B3.63%
2010S$0.36 B47.65%
2009S$0.24 B235.9%
2008S$72.58 M-58.72%
2007S$0.17 B262.33%
2006S$48.53 M-64.73%
2005S$0.13 B-40.4%
2004S$0.23 B

End of Day market cap according to different sources

On Feb 2nd, 2026 the market cap of Corcept Therapeutics was reported to be:

S$5.43 Billion
by Nasdaq info icon info icon
S$5.44 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$705.73 B 12,860.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$367.90 B 6,656.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$192.42 B 3,433.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.188 T 21,720.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$359.47 B 6,501.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$144.43 B 2,552.37%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
S$2.34 B-56.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$1.06 B-80.49%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$14.13 B 159.53%๐Ÿ‡บ๐Ÿ‡ธ USA